HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicolas Frances Selected Research

Nicolas Frances Research Topics

Disease

6Neoplasms (Cancer)
11/2023 - 01/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 12/2017
1Disease Progression
01/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Peripheral Nervous System Diseases (PNS Diseases)
12/2020
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2019
1Breast Neoplasms (Breast Cancer)
01/2012
1Neutropenia
01/2011
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2011
1Sepsis (Septicemia)
01/2011
1Dihydropyrimidine Dehydrogenase Deficiency
01/2011
1Diarrhea
05/2009
1Fever (Fevers)
05/2009

Drug/Important Bio-Agent (IBA)

3Capecitabine (Xeloda)FDA Link
01/2012 - 05/2009
2Biomarkers (Surrogate Marker)IBA
11/2023 - 12/2016
2Paclitaxel (Taxol)FDA LinkGeneric
11/2023 - 12/2020
2Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2017 - 12/2016
2Gefitinib (Iressa)FDA Link
12/2017 - 12/2016
1PlatinumIBA
11/2023
1glofitamabIBA
01/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1cibisatamabIBA
01/2021
1Bispecific AntibodiesIBA
01/2021
1AntigensIBA
01/2021
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1RisdiplamIBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1ErbB Receptors (EGF Receptor)IBA
12/2017
1Tyrosine Kinase InhibitorsIBA
12/2017
1Docetaxel (Taxotere)FDA Link
01/2012
1Fluorouracil (Carac)FDA LinkGeneric
01/2011

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2023 - 01/2011
1Therapeutics
01/2022
1Immunotherapy
01/2021
1Aftercare (After-Treatment)
12/2017
1Chemoradiotherapy
01/2011